Indeed, Gong et al. recently identified two unique secretory PD-L1 shear variants lacking transmembrane regions in non-small cell lung cancer (NSCLC) patients resistant to PD-L1 antibody treatment. This evidence concerns the gene CD274 and non-small cell lung carcinoma.